Emerging roles of E2Fs in cancer: an exit from cell cycle control
Mutations of the retinoblastoma tumour suppressor gene (RB1) or components regulating
the RB pathway have been identified in almost every human malignancy. The E2F …
the RB pathway have been identified in almost every human malignancy. The E2F …
The cell-cell adhesion molecule E-cadherin
F Van Roy, G Berx - Cellular and molecular life sciences, 2008 - Springer
This review is dedicated to E-cadherin, a calcium-dependent cell-cell adhesion molecule
with pivotal roles in epithelial cell behavior, tissue formation, and suppression of cancer. As …
with pivotal roles in epithelial cell behavior, tissue formation, and suppression of cancer. As …
Involvement of members of the cadherin superfamily in cancer
G Berx, F Van Roy - Cold Spring Harbor perspectives in …, 2009 - cshperspectives.cshlp.org
We review the role of cadherins and cadherin-related proteins in human cancer. Cellular
and animal models for human cancer are also dealt with whenever appropriate. E-cadherin …
and animal models for human cancer are also dealt with whenever appropriate. E-cadherin …
Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
Y Dai, X Zhang, Y Ou, L Zou, D Zhang, Q Yang… - Cell Communication and …, 2023 - Springer
Breast cancer exhibits the highest global incidence among all tumor types. Regardless of
the type of breast cancer, metastasis is a crucial cause of poor prognosis. Anoikis, a form of …
the type of breast cancer, metastasis is a crucial cause of poor prognosis. Anoikis, a form of …
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms
ZS Lima, M Ghadamzadeh, FT Arashloo… - Journal of hematology & …, 2019 - Springer
Breast cancer is the most common malignancy in women all over the world. Genetic
background of women contributes to her risk of having breast cancer. Certain inherited DNA …
background of women contributes to her risk of having breast cancer. Certain inherited DNA …
CDH1promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer
JRF Caldeira, ÉC Prando, FC Quevedo, FAM Neto… - BMC cancer, 2006 - Springer
Background The E-cadherin gene (CDH1) maps, at chromosome 16q22. 1, a region often
associated with loss of heterozygosity (LOH) in human breast cancer. LOH at this site is …
associated with loss of heterozygosity (LOH) in human breast cancer. LOH at this site is …
Autophagy, mitochondrial quality control, and oncogenesis
S Jin - Autophagy, 2006 - Taylor & Francis
Cancer is a disease associated with aging. More than 80% of human cancers are diagnosed
in people aged 55 years or older. Autophagy has recently been demonstrated to be a novel …
in people aged 55 years or older. Autophagy has recently been demonstrated to be a novel …
The spectrum of genetic mutations in breast cancer
A Sheikh, SA Hussain, Q Ghori, N Naeem… - Asian Pacific Journal …, 2015 - koreascience.kr
Breast cancer is the most common malignancy in women around the world. About one in 12
women in the West develop breast cancer at some point in life. It is estimated that 5%-10 …
women in the West develop breast cancer at some point in life. It is estimated that 5%-10 …
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
AM Cleton-Jansen - Breast Cancer Research, 2001 - Springer
Loss of heterozygosity at the long arm of chromosome 16 is one of the most frequent genetic
events in breast cancer. In the search for tumour suppressor genes that are the target of loss …
events in breast cancer. In the search for tumour suppressor genes that are the target of loss …
The CHEK2* 1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families
RA Oldenburg, K Kroeze-Jansema, J Kraan, H Morreau… - Cancer research, 2003 - AACR
The frame-shifting mutation 1100delC in the cell-cycle-checkpoint kinase 2 gene (CHEK2)
has been reported to be associated with familial breast cancer in families in which mutations …
has been reported to be associated with familial breast cancer in families in which mutations …